Grant Number:	5R01CA218123-05 Interpret this number
Primary Investigator:	Park, Elyse
Organization:	Massachusetts General Hospital
Project Title:	Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening
Fiscal Year:	2022

Abstract Lung cancer accounts for 27% of U.S. cancer deaths. The National Lung Screening Trial demonstrated that lung cancer screening (LCS) with low-dose computed tomography (LDCT) reduces lung cancer mortality. Guidelines recommend offering annual LCS accompanied by smoking cessation treatment to high-risk, older individuals. Payers cover LCS for high-risk individuals, and Medicare requires LCS sites to offer smoking cessation to current smokers. Health care systems adopting LCS have a critical new opportunity to deliver tobacco cessation treatment to smokers at a teachable moment. However, an optimal treatment strategy for these long-term, highly dependent smokers undergoing LCS has not yet been determined, and there are challenges to integrating tobacco treatment services into high-volume radiology practices. We propose a hybrid effectiveness-implementation design to examine the development, integration, and implementation of a novel, personalized, English and Spanish language, evidence-based smoking cessation intervention into LCS sites in a large, diverse, integrated health care delivery system, comprised of two networks. To maximize the reach of tobacco treatment, smokers will be offered personalized assistance and outreach at up to 3 time points (LCS test order, scan, and results). We will utilize novel health information technology (IT) platforms to promote patient outreach and access, using technologies like patient portals, informational videos (Vidscrip), and video- conferencing. Guided by the Health Belief and Self Regulation models with a chronic disease management perspective, the multi-component LCS-tailored intervention targets the older, long-term, heavy smokers who will undergo LCS. It provides counseling support and pharmacotherapy (nicotine replacement therapy [NRT]); is personalized to smokers' risk perceptions, readiness to quit, and LCS results; and systematic screening and referral to community-based resources to address social barriers to quitting. A centralized tobacco treatment specialist will deliver the intervention in a series of proactive motivational telephone- or videoconferencing- based sessions to sustain patient engagement. A randomized trial with a factorial design will test 3 intervention components that vary by (1) counseling duration, (2) NRT dose, and (3) systematic screening and referral for social barriers to quitting among 960 current smokers undergoing LCS at 6 screening sites. The primary outcome is biochemically-validated 7-day point-prevalence tobacco abstinence rates at 6 months. Exploratory analyses will identify patient- and LCS-level factors that moderate the relationship between intervention group and smoking outcomes, including socio-demographic characteristics, medical and smoking characteristics, and LCS-related factors (i.e., LCS result, time point of study entry). Guided by the RE-AIM framework, we will conduct a rigorous mixed methods evaluation of the intervention's reach, adoption, implementation (including cost-effectiveness from provider, payer and patient perspectives), and maintenance. Our program could provide health systems nationally with a sustainable model to integrate tobacco treatment into LCS screening.




Budget impact analysis for implementation decision making, planning, and financing.
Authors: Smith N.R. , Levy D.E. .
Source: Translational Behavioral Medicine, 2024-01-11 00:00:00.0; 14(1), p. 54-59.
PMID: 37776567
Related Citations

Social Determinants of Health in Imaging-based Cancer Screening: A Case-based Primer with Strategies for Care Improvement.
Authors: Abraham P. , Haddad A. , Bishay A.E. , Bishay S. , Sonubi C. , Jaramillo-Cardoso A. , Sava M. , Yee J. , Flores E.J. , Spalluto L.B. .
Source: Radiographics : A Review Publication Of The Radiological Society Of North America, Inc, 2023 Nov; 43(11), p. e230008.
PMID: 37824411
Related Citations

Impact of High Neighborhood Socioeconomic Deprivation on Access to Accredited Breast Imaging Screening and Diagnostic Facilities.
Authors: Mango V.L. , Stoeckl E.M. , Reid N.J. , Miles R.C. , Flores E.J. , Weissman I.A. , Wagner A. , Morla A. , Jose O. , Narayan A.K. .
Source: Journal Of The American College Of Radiology : Jacr, 2023 Jul; 20(7), p. 634-639.
EPub date: 2023-05-23 00:00:00.0.
PMID: 37230233
Related Citations

Rate of True-Positive Findings of COVID-19 Typical Appearance at Chest CT per RSNA Consensus Guidelines in an Increasingly Vaccinated Population.
Authors: Polyakov N.J. , Som A. , Mercaldo N.D. , Di Capua J. , Little B.P. , Flores E.J. .
Source: Radiology, 2023 Mar; 306(3), p. e220680.
EPub date: 2022-09-06 00:00:00.0.
PMID: 36066367
Related Citations

Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment.
Authors: Park E.R. , Neil J.M. , Noonan E. , Howard S.E. , Gonzalez I. , Marotta C. , Wint A.J. , Levy D.E. , Chang Y. , Rigotti N.A. , et al. .
Source: Jnci Cancer Spectrum, 2022-11-01 00:00:00.0; 6(6), .
PMID: 36350049
Related Citations

National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening-Eligible Patients.
Authors: Meza R. , Jeon J. , Jimenez-Mendoza E. , Mok Y. , Cao P. , Foley K.L. , Chiles C. , Ostroff J.S. , Cinciripini P.M. , Minnix J. , et al. .
Source: Jto Clinical And Research Reports, 2022 Jul; 3(7), p. 100352.
EPub date: 2022-06-03 00:00:00.0.
PMID: 35815319
Related Citations

Integrating tobacco treatment into lung cancer screening practices: Study protocol for the Screen ASSIST randomized clinical trial.
Authors: Neil J.M. , Marotta C. , Gonzalez I. , Chang Y. , Levy D.E. , Wint A. , Harris K. , Hawari S. , Noonan E. , Styklunas G. , et al. .
Source: Contemporary Clinical Trials, 2021 Dec; 111, p. 106586.
EPub date: 2021-10-01 00:00:00.0.
PMID: 34606988
Related Citations

A Web-Based Intervention to Increase Smokers' Intentions to Participate in a Cessation Study Offered at the Point of Lung Screening: Factorial Randomized Trial.
Authors: Neil J.M. , Chang Y. , Goshe B. , Rigotti N. , Gonzalez I. , Hawari S. , Ballini L. , Haas J.S. , Marotta C. , Wint A. , et al. .
Source: Jmir Formative Research, 2021-06-30 00:00:00.0; 5(6), p. e28952.
EPub date: 2021-06-30 00:00:00.0.
PMID: 34255651
Related Citations

Predictors of Enrollment of Older Smokers in Six Smoking Cessation Trials in the Lung Cancer Screening Setting: The Smoking Cessation at Lung Examination (SCALE) Collaboration.
Authors: Eyestone E. , Williams R.M. , Luta G. , Kim E. , Toll B.A. , Rojewski A. , Neil J. , Cinciripini P.M. , Cordon M. , Foley K. , et al. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2021-06-02 00:00:00.0; , .
EPub date: 2021-06-02 00:00:00.0.
PMID: 34077535
Related Citations

Increasing Lung Screening in the Latino Community.
Authors: Flores E.J. , Irwin K.E. , Park E.R. , Carlos R.C. .
Source: Journal Of The American College Of Radiology : Jacr, 2021 May; 18(5), p. 633-636.
PMID: 33958079
Related Citations

Increasing Lung Screening in the Latino Community.
Authors: Flores E.J. , Irwin K.E. , Park E.R. , Carlos R.C. .
Source: Journal Of The American College Of Radiology : Jacr, 2021 May; 18(5), p. 633-636.
PMID: 33958079
Related Citations

Analysis of the Effects of a Patient-Centered Rideshare Program on Missed Appointments and Timeliness for MRI Appointments at an Academic Medical Center.
Authors: Whorms D.S. , Narayan A.K. , Pourvaziri A. , Miles R.C. , Glover M. , Herrington J. , Saini S. , Brink J.A. , Flores E.J. .
Source: Journal Of The American College Of Radiology : Jacr, 2021 Feb; 18(2), p. 240-247.
EPub date: 2020-08-10 00:00:00.0.
PMID: 32791235
Related Citations

Impact of the COVID-19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances.
Authors: Park E.R. , Chiles C. , Cinciripini P.M. , Foley K.L. , Fucito L.M. , Haas J.S. , Joseph A.M. , Ostroff J.S. , Rigotti N.A. , Shelley D.R. , et al. .
Source: Cancer, 2020-10-13 00:00:00.0; , .
EPub date: 2020-10-13 00:00:00.0.
PMID: 33048350
Related Citations